Central Mass EMS Corp.    CMEMSC OFFICE: (508) 854-0111   |   CMED 24/7 Phone: 508-854-0100

Announcements

Did you receive some KN95 masks at your service and have a concern about their clinical use? Here is some guidance from the FDA released on 4/3/2020.

The US Food and Drug Administration on Friday changed its position on a sought-after type of respirator from China, the KN95.

In response to continued respirator shortages, the FDA issued new guidance, authorizing KN95 respirators if certain criteria are met, including evidence demonstrating that the respirator is authentic.
The move comes after conflicting government guidance caused confusion over how these masks should be used and whether they could be imported into the US.

Health Care Professional VolunteersTo support ongoing COVID-19 emergency response efforts, the Baker-Polito Administration has partnered with the Massachusetts Medical Society to match volunteers with our communities and health care providers based on skillsets and need. There is an immediate need for respiratory therapists and public health nurses, and the administration is asking health care professionals interested in volunteering to sign up at MAResponds.org.

Stryker announced today that the company is launching a voluntary field action on specific units of the LIFEPAK 15 monitor/defibrillators.

The company is notifying a population of LIFEPAK 15 customers of an issue that may cause their devices to fail to deliver a defibrillation shock after the “Shock” button on the keypad is pressed. This is a result of oxidation that may have formed over time within the “Shock” button.

Beginning December 2, 2019, there is a new direct-to-CT pathway specifically for trauma patients transported to UMass University.  This is designed to get patients who have falls on anticoagulants to CT quickly, but only applies to patients who are otherwise uncomplicated.  Read the memo from UMass-Memorial Medical Center here.  

Notice

FDA Alert: Extended Use Dates Provided by Pfizer to Assist with Emergency Injectable Drug Shortages

The FDA is alerting the health care and emergency response community that due to the ongoing critical shortages of injectable drugs used in critical care, Pfizer has provided updated dates through which some of these injectable drugs, manufactured by Hospira Inc., a Pfizer company, may be used beyond the manufacturer’s labeled expiration date. To help ensure patient safety, these products should have been — and should continue to be — stored as per labeled conditions. For specific information and the full FDA alert, go to https://www.fda.gov/drugs/drug-shortages/search-list-extended-use-dates-assist-drug-shortages.

Office of Emergency Medical Services

Department of Public Health                                                                                                               

Commonwealth of Massachusetts

Notice

Stryker Lifepak 15 Urgent Medical Device Safety Notice and Correction

The Massachusetts Department of Public Health has been alerted that Stryker is conducting a voluntary Field Action for specific Lifepak 15 Monitor/Defibrillator devices that may lock-up after a defibrillation shock is delivered. This condition is defined as a blank monitor display with LED lights on, indicating power to the device, but no response in the keypad and device functions.

Please read the Clinical Advisory issued June 22, 2018 for important information on the increase of opioid-related overdose deaths that have also been positive for cocaine.